S
Suzanne Oparil
Researcher at University of Alabama at Birmingham
Publications - 941
Citations - 122414
Suzanne Oparil is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Blood pressure & Angiotensin II. The author has an hindex of 106, co-authored 885 publications receiving 113983 citations. Previous affiliations of Suzanne Oparil include Michigan State University & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
Michael E. Ernst,Barry R. Davis,Elsayed Z. Soliman,Ronald J. Prineas,Peter M. Okin,Alokananda Ghosh,William C. Cushman,Paula T. Einhorn,Suzanne Oparil,Richard H. Grimm,Richard H. Grimm +10 more
TL;DR: It is concluded that risk reductions associated with C treatment in secondary end points of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial cannot be attributed to differential improvements in electrocardiography LVH.
Journal ArticleDOI
Hormonal and haemodynamic responses to upper abdominal surgery during isoflurane and balanced anaesthesia.
Simon Gelman,Jorge E. Rivas,Hamdi Erdemir,Suzanne Oparil,James Proctor,Thomas MacKrell,L. R. Smith +6 more
TL;DR: Haemodynamic stability was maintained despite a two- to three-fold increase in cortisol which occurred during the operation and immediate postoperative period, and high performance liquid gas chromatography in blood samples at different stages perioperatively.
Journal Article
Triple-Combination Treatment with Olmesartan Medoxomil/ Amlodipine/ Hydrochlorothiazide in Hispanic/Latino Patients with Hypertension: The TRINITY Study
Andrew J. Lewin,Dean J. Kereiakes,Steven G. Chrysant,Joseph L. Izzo,Suzanne Oparil,James Lee,Victor Fernandez,Michael Melino +7 more
TL;DR: The efficacy of triple-drug therapy in achieving BP goal was sustained long-term (40-week open-label extension period) in Hispanic/Latino and non-Hispanic/ Latino participants.
Journal ArticleDOI
Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Sverre E. Kjeldsen,Paulette A. Lyle,Andrew M. Tershakovec,Richard B. Devereux,Suzanne Oparil,Björn Dahlöf,Ulf de Faire,Frej Fyhrquist,Hans Ibsen,Krister Kristianson,Ole Lederballe-Pedersen,Lars H Lindholm,Markku S. Nieminen,Per Omvik,Hans Wedel +14 more
TL;DR: Use of ARBs alone or in combination with other classes of antihypertensive agents to lower blood pressure and/or medications to control other conditions reduces risk of cardiovascular disease outcomes and Type 2 diabetes with excellent tolerability.
Journal ArticleDOI
Renin inhibition: should it supplant ACE inhibitors and ARBS in high risk patients?
Krishna K. Gaddam,Suzanne Oparil +1 more
TL;DR: The potential advantages and disadvantages of aliskiren therapy versus existing RAAS antagonists in treating hypertension and target organ damage are under investigation.